Mesmo em um mercado forte, os CROs enfrentam alguns desafios de longo prazo que podem remodelar a indústria nos próximos cinco a dez anos.
EDUCAÇÃO
- MBA, Fuqua Scholar, Fuqua School of Business, Duke University
- MA, Matemática, Universidade de Illinois em Urbana-Champaign
Chris Bennani is a core member of the Health Care practice at Boston Consulting Group. He is the global leader for the firm’s work on life sciences research and IVD (in vitro diagnostic) tools and services, and is part of the leadership team for R&D operations. In addition, he serves as the Health Care practice node for the Boston office.
Chris has experience working across the biopharma value chain on operational, organizational, and strategy topics, including CDMO (contract development and manufacturing organization) and CRO (contract research organization). In addition to biopharma, Chris has worked with clients in the pharmaceutical, life sciences, and medical devices and technology indutries.
Before joining BCG, Chris worked as director in strategy and business development roles in the bioscience division of Millipore and as a senior associate in the investment team at the private equity fund Audax.